Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata
Status:
Completed
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the efficacy and safety of combined CO2 fractional
laser with Bimatoprost 0.03% as novel treatment of alopecia areata.
The main question to study is will the bimatoprost facilitate hair growth if added to
fractional CO2 laser treatment in Alopecia areata.